India pharma investors think small as U.S. compliance woes hit heavyweights

MUMBAI (Reuters) - Investors in India's $15 billion pharmaceutical industry are favoring smaller firms with little or no exposure to the United States, where increasingly tight regulatory controls have burnt two of the country's biggest drugmakers over the past month.

http://ift.tt/1Mt7kbR

from Reuters: Health News
via animenewspro